Compare Asana Inc. (ASAN) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Asana Inc. vs Novartis AG — how do they compare? Asana Inc. trades at $9.18 (market cap $2.13B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 138.7× Asana Inc.'s market cap, and Novartis AG pays a 3.07% dividend while Asana Inc. pays none. Which is the better fit depends on your goals.
| ASAN | NVS | |
|---|---|---|
Market Cap | $2.13B | $295.37B |
Sector | Consumer Cyclical | Health |
52-Week High | $15.19 | $168.62 |
52-Week Low | $5.46 | $119.31 |
Enterprise Value | $1.96B | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Asana Inc.
Asana Inc is a software company. The company provides a platform for work management that helps teams orchestrate work, from daily tasks to cross-functional strategic initiatives. It helps plan marketing campaigns, streamlines processes, manages sales, and manage product launches. Also, the company provides project management and workflow management solutions.
Read more on ASAN →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
